Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 2 (ANKRD2)

Target
ANKRD2
Molecular classification
Muscle ankyrin repeat protein (MARP) family, Structural protein, Scaffold protein, Other
01

Overview

Ankyrin repeat domain-containing protein 2 (ANKRD2, also called ARPP) is a member of the muscle ankyrin repeat protein (MARP) family, highly expressed in cardiac and skeletal muscle. It contains ankyrin repeats, a PEST-like and lysine-rich N-terminal region, and a proline-rich C-terminal region. ANKRD2 is primarily associated with titin at the sarcomere I-band and translocates to the nucleus under stress, linking mechanical muscle signals to gene regulation. It interacts with transcription factors (p53, PML, NF-κB p50, YB-1) and signaling proteins (Akt2), modulating muscle differentiation, repair, and inflammatory signaling. Its expression is induced following muscle injury and altered in several pathological conditions (cardiac, neurodegenerative, muscular, and cancer). While not a traditional drug target, its modulation may impact muscle physiology and disease progression

Other names
ARPPhArppSkeletal muscle ankyrin repeat proteinAnkyrin repeat domain 2 (stretch responsive muscle)
02

Mechanism of action

No direct drug mechanism documented. Functionally, ANKRD2 acts by: - Binding and modulating transcription factors such as p53, PML, YB-1, and NF-κB p50 - Regulating inflammation and stress response signaling

03

Biological functions

Mechanosensing in striated muscle (especially the cardiac and skeletal muscle)Regulation of muscle gene expressionModulation of stress and inflammatory responseRegulation of myogenic differentiationStructural support (sarcomere organization)Signal transduction between sarcomere and nucleus
04

Disease associations

Dilated cardiomyopathy (expression changes associated with disease)Amyotrophic lateral sclerosis (ALS; altered expression)Muscular dystrophy/myositis (upregulated in models)Diabetes (altered expression)Cancer (roles in tumor progression/metastasis, osteosarcoma, head and neck squamous cell carcinoma)Other: serves as a biomarker for differential diagnosis between oncocytoma and chromophobe renal cell carcinoma
05

Biomarkers

Elevated levels can act as biomarkers in skeletal muscle injury repairDifferential diagnostic biomarker for certain renal carcinomasPossible biomarker in muscle pathologies and cancer

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 2 (ANKRD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 2 (ANKRD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call